论文部分内容阅读
目的:观察匹多莫德(PT)治疗反复呼吸道感染(RRI)的治疗效果。方法:将84名符合要求的儿童病患分成两组各42名,均实施一般的抗感染治疗。其中实验组再加匹多莫德治疗,对照组则不再使用任何治疗方式。各组在服药两个月后开始观察,连续观察两年半的时间,记录其再次感染的次数,感染后各症状恢复的情况以及治疗的总有效率。结果:实验组在观察期间再次感染次数平均2.4±0.8次,对照组则为5.6±2.4次:实验组发热、咳嗽等症状恢复时间分别为1.8±0.7d、1.7±0.5d,对照组则为2.8±0.9d、2.7±0.8d。并且实验组治疗的总有效率为92.8%,而对照组的则为61.9%。结论:匹多莫德治疗RRI具有显著的优势,不仅表现在将治疗病程缩短,使病患在更短的时间内恢复健康,而且可以提高总体的治疗有效率。值得临床上广泛推广。
Objective: To observe the therapeutic effect of pidotimod (PT) on patients with recurrent respiratory tract infection (RRI). METHODS: Eighty-four eligible children were divided into two groups of 42, each receiving general anti-infective therapy. The experimental group plus pidotimod treatment, the control group is no longer used any treatment. Each group began to observe after taking medicine for two months, continuously observed for two and a half years, recorded the number of re-infection, the recovery of symptoms after infection, and the total effective rate of treatment. Results: In the experimental group, the average number of infections was 2.4 ± 0.8 times during the observation period and 5.6 ± 2.4 times in the control group. The recovery time of fever, cough and other symptoms were 1.8 ± 0.7d and 1.7 ± 0.5d respectively in the experimental group and 2.8 ± 0.9d, 2.7 ± 0.8d. And the total effective rate of the experimental group was 92.8%, while the control group was 61.9%. Conclusion: Pidotimod has significant advantages in the treatment of RRI, not only in shortening the duration of treatment, in recovering the patient in a shorter period of time, but also in improving overall treatment efficiency. Worth widespread clinical promotion.